Biosensors International Group develops, manufactures and commercializes innovative medical devices used in interventional cardiology and critical care procedures. The Company is well positioned to emerge as a leader in drug-eluting stents. It has three separate stent programs, BioMatrix, a drug eluting stent (“DES”) with a bio-degradable polymer, Gazelle, a bare-metal stent, and BioFreedom, a completely polymer-free drug-eluting stent in development. The Company is listed on Singapore Stock Exchange.
Location: Singapore
Investors 2
| Date | Name | Website |
| - | SAIF Partn... | sbaif.com |
| - | Hony Capit... | honycapita... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 09.11.2022 | Huadi International Group Co., Ltd. Announces Closing of $25... | - | globenewsw... |
| 07.11.2022 | Huadi International Group Co., Ltd. Announces Pricing of $25... | - | globenewsw... |
| 11.06.2020 | Blue Sail Medical acquires Swiss medtech company NVT AG | The finalization of this deal brings together NVT’s expertise in innovative Transcatheter Aortic Val... | startuptic... |
| 11.06.2020 | Blue Sail Medical acquires Swiss medtech company NVT AG | startuptic... | |
| 18.10.2016 | HK: Good Parents closes $2m seed in round led by Jungle Vent... | Premium Good Parents Inc., a startup launched in October 2015 focused on children’s health and welln... | dealstreet... |